paper on Small Cell Lung Cancer

I need a 4 pg. paper not including title and reference page.

 

correc,t edited, and add to  my  previously submitted papers into a clean, crisp document about Small cell lung cancer . I have attched the documents of the work that I have already done. I guess read it over and revise. They are labled assignment unit 1 3 and 7. Then I want  you to  finish the paper by writing a conclusion. That includes a detailed proposal of solution for your topic problem. Propose a timetable for change to occur, both time-wise and community-wise. For example, will effects of change be observed in current community or will change be generational.

Please include a title and reference page which reflects your citations as they are found within your paper

 

So paper should include introduction of small cell lung cancer, main body portion  by addressing details of the problem, how it affects your identified population, and prognosis if left unchecked (personally, financially, and community-wise). and a conclusion. of coarse a title page and a reference page APA formatt.

 

3

Kimberly Crawford

Kaplan University

HS310:

August 27, 2013

Small Cell Lung Cancer

Small cell Lung cancer (SCLC) is a deadly disease directly linked to tobacco smoking. 15-18% of lung cancers are as a result of small cell lung cancer although the incidence of this type of cancer has gone down in the recent years. It develops in the lungs and spreads very fast to other parts of the body. It may be treated by chemotherapy, a combination of radiation therapy and chemotherapy and less frequently by surgery (Sørensen et al,Pp. v120-v125). This research paper discusses the fact that small cell lung cancer is not curable but it is treatable.

As it is common in all cancers, small cell cancer is incurable in the basic sense that it cannot cure and hence remains in the part of the body where it develops or spreads to other parts of the body. The paper will dig deep into the nature, extent, duration and possible types of the damage caused by tobacco smoking on the lungs that makes it incurable. The meaning, types and duration of treatment are important aspects which will need to be focused on in this research. Several questions will need to be answered such as: Which mode of treatment is effective for the different categories of small cell lung cancer? Why do more than one type of treatment of SCLC? Which drugs are available for chemotherapy treatment? Which gender is more affected and how do they respond to treatment? What is the economic impact of treatment of SCLC to both individuals and the state of origin? Finally, the paper will draw conclusion on the best method of treatment and give recommendations on how it should be controlled (Ochi et al, 20-40).

References

Ochi, Nobuaki, Katsuyuki Kiura , Mitsune Tanimoto, Masahiro Tabata, Akiko Hisamoto, Eiki Ichihara, Yoshiro Fujiwara, Isao Oze, Nagio Takigawa, and Katsuyuki Hotta mail. “Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades .” PLoS ONE 1 (2013): 20-40. Print.

Sørensen, M., E. Felip, and M. Pijls-Johannesma. “Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.” Annals of Oncology 21.Issue suppl 5 (2010): Pp. v120-v125. Print.

Small cell Lung cancer

Kimberly Crawford

Kaplan University

HS310:

September 6, 2013

Small cell Lung cancer (SCLC) is a deadly disease directly linked to tobacco smoking. 15-18% of lung cancers are as a result of small cell lung cancer although the incidence of this type of cancer has gone down in the recent years. It develops in the lungs and spreads very fast to other parts of the body. It may be treated by chemotherapy, a combination of radiation therapy and chemotherapy and less frequently by surgery (Sørensen et al,Pp. v120-v125). As it is common in all cancers, small cell cancer is incurable in the basic sense that it cannot cure and hence remains in the part of the body where it develops or spreads to other parts of the body.

Most cases of small cell lung cancer are due to smoking, although other causes such as exposure to radon, Inhaled chemicals or minerals such as arsenic, beryllium, cadmium, silica, vinyl chloride, nickel compounds, chromium compounds, coal products, mustard gas, and chloromethyl ethers asbestos can contribute as well (Ochi et al, 20-40).

References

Ochi, Nobuaki, Katsuyuki Kiura , Mitsune Tanimoto, Masahiro Tabata, Akiko Hisamoto, Eiki Ichihara, Yoshiro Fujiwara, Isao Oze, Nagio Takigawa, and Katsuyuki Hotta mail. “Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades .” PLoS ONE 1 (2013): 20-40. Print.

Sørensen, M., E. Felip, and M. Pijls-Johannesma. “Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.” Annals of Oncology 21.Issue suppl 5 (2010): Pp. v120-v125. Print.

Small-Cell Lung Cancer

Kimberly Crawford

Kaplan University

October 4, 2013

Small-Cell Lung Cancer

While doing research on Small-Cell Lung Cancer (SCLC). I have learned that SCLC or oat cell carcinoma is a respiratory disorder caused by frequent smoking habit of tobacco and specially radon and asbestos gas. It causes around 20% of all the cancer cases which begins from developing in the bronchi and after completely destroyed lungs moves to affect next parts of the body. This disease is only curable if treated earlier. Populations mostly affected with SCLC 50% are of age 65, 30% are above the age of 30 and 20% under age of 30. The research showed that young people have more capacity to tolerate therapeutic remedies than old people. SCLC is the most leading cause of death in men than women by cancer. The major symptoms which associated with SCLC patients include persistent cough, coughing blood, recurring pneumonia, shortness of breath and other. Prognosis of SCLC should do before going too much late. As late diagnosis is 98% useless for SCLC patients. The most effective and suggestive treatments consider for SCLC patients include chemotherapy and radiotherapy. However other treatments like Sabarubicin also develop to treat this disease at some extent.

References

Argiris A and Murren JR .(2001). Staging and clinical prognostic factors for small-cell lung cancer. Cancer J 7 (5): 437–47.

Capizzello A, Peponi E, Simou N. (2011). Pure small cell carcinoma of the prostate: a case report and literature review. Case Rep Oncol 4 (1): 88–95. doi:10.1159/000324717.

Giaccone, G. (2012). Systemic treatment of non-small cell lung cancer. Oxford: Oxford University Press.

Ismaili N (2011). A rare bladder cancer – small cell carcinoma: review and update. Orphanet Journal of Rare Diseases 6 (75).

Shepherd F.A. (2010). Surgery for limited stage small cell lung cancer: time to fish or cut bait. J Thorac Oncol 5 (2): 147–9.

Sørensen, M., E. Felip, and M. Pijls-Johannesma. (2010). Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21.Issue suppl 5: Pp. v120-v125. Print.